NOV Inc. Profile Avatar - Palmy Investing

NOV Inc.

NOV Inc. designs, constructs, manufactures, and sells systems, components, and products for oil and gas drilling and production, and industrial and renewable energy sectors worldwide. The company operates through three segments: Wellbore Technologies, Co…

Oil & Gas Equipment & Services
US, Houston [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 43% Somewhat Weak
Profitability n.A. n.A.
Fin. Growth 17% Weak
Leverage & Liquidity 17% Weak
Per Share Metrics 33% Weak
Fin. Health n.A. n.A.
Fundamentals

Valuation

Metric Q2 Q3 Δ in %
EV/EBITDA 22.79 27.32 22.25
Graham Fair Price -23.07 11.09 14.42
PEG 218.51 -0.29 0.09
Price/Book -15.41 0.97 1.14
Price/Cash Flow 8.30 22.60 20.87
Prices/Earnings 49.01 12.04 8.08
Price/Sales -13.31 2.86 3.30
Price/FCF 8.30 22.60 20.87
Naive Interpretation member
01 - Valuation · Somewhat Weak
Fundamentals

Profitability

Metric Q2 Q3 Δ in %
Gross Profit Margin -34.21 0.21 0.33
Operating Margin -55.81 0.09 0.20
ROA -43.11 0.01 0.02
ROE 0.04 0.02 -43.23
ROIC 0.04 0.02 -57.04
Naive Interpretation member
02 - Profitability · Not Interpreted
Fundamentals

Financial Growth

Metric Q2 Q3 Δ in %
Debt QOQ < 0.005 -0.03 -98.55
Dividends QOQ 0.50 -0.03 -94.77
EBIT QOQ 1.74 -0.56 -67.65
EPS QOQ 0.90 -0.42 -53.22
FCF QOQ 3.38 -0.21 -93.83
Revenue QOQ 0.03 -0.01 -60.81
Naive Interpretation member
03 - Financial Growth · Weak
Fundamentals

Leverage & Liquidity

Metric Q2 Q3 Δ in %
Assets Turnover n.A. n.A. n.A.
Days Inventory Outstanding (DIO) 129.85 110.96 -14.55
Days Sales Outstanding (DSO) 106.65 105.98 -0.63
Inventory Turnover 0.69 0.81 17.03
Debt/Capitalization 0.22 0.21 -5.16
Quick Ratio 1.64 1.65 0.33
Naive Interpretation member
04 - Leverage & Liquidity · Weak
Fundamentals

Per Share Metrics

Metric Q2 Q3 Δ in %
Book Value 16.28 16.62 2.08
Cash 2.09 2.51 20.02
Capex 0.21 0.21 0.77
Free Cash Flow 0.89 0.71 -20.25
Revenue 5.61 5.59 -0.37
Naive Interpretation member
05 - Per Share Metrics · Weak
Fundamentals

Financial Health

Metric Q2 Q3 Δ in %
Current Ratio 2.61 2.57 -1.29
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 3.94 5.04 27.82
Naive Interpretation Member
06 - Financial Health · Bad
End of NOV's Analysis
CIK: 1021860 CUSIP: 62955J103 ISIN: US62955J1034 LEI: - UEI: -
Secondary Listings
NOV has no secondary listings inside our databases.